The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer
Authors
Keywords
-
Journal
Human Cell
Volume 33, Issue 4, Pages 1229-1239
Publisher
Springer Science and Business Media LLC
Online
2020-09-03
DOI
10.1007/s13577-020-00422-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway
- (2020) Yue-Li Sun et al. BMC CANCER
- The emerging roles of WBP2 oncogene in human cancers
- (2020) Hossein Tabatabaeian et al. ONCOGENE
- Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
- (2019) Max D. Wellenstein et al. NATURE
- p21 in Cancer Research
- (2019) Shamloo et al. Cancers
- MicroRNA-143-3p targets pyruvate carboxylase expression and controls proliferation and migration of MDA-MB-231 cells
- (2019) Pannapa Pinweha et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-143-3p inhibits the proliferation, cell migration and invasion of human breast cancer cells by modulating the expression of MAPK7
- (2018) Chongsheng Xia et al. BIOCHIMIE
- High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival
- (2018) Zhanwei Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- ErbB4 receptor polymorphism 2368A>C and risk of breast cancer
- (2018) Masoumeh Mansouri Bidkani et al. BREAST
- ESR1 single nucleotide polymorphism rs1062577 (c.*3804T > A) alters the susceptibility of breast cancer risk in Iranian population
- (2017) Zahra Dehghan et al. GENE
- The association between rs1972820 and the risk of breast cancer in Isfahan population
- (2017) Kamran Ghaedi et al. Journal of Cancer Research and Therapeutics
- Cooverexpression of EpCAM and c-myc genes in malignant breast tumours
- (2017) SAMIRA SADEGHI et al. JOURNAL OF GENETICS
- Oncogenic long noncoding RNA landscape in breast cancer
- (2017) Shouping Xu et al. Molecular Cancer
- Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
- (2017) Rimi Hamam et al. Cell Death & Disease
- MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42
- (2016) Jinjiang Chou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MALAT1 long non-coding RNA in cancer
- (2016) Rei Yoshimoto et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
- (2016) Oluwaseun Adebayo Bamodu et al. BMC CANCER
- rs11895168 C allele and the increased risk of breast cancer in Isfahan population
- (2016) Zohreh Salimi et al. BREAST
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer
- (2016) E. Latorre et al. CANCER RESEARCH
- Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer
- (2016) Mahdieh Jadaliha et al. Oncotarget
- Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
- (2015) L Golmard et al. ONCOGENE
- LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
- (2015) X Xue et al. ONCOGENE
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
- (2014) Eva Maria Ciruelos Gil CANCER TREATMENT REVIEWS
- miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer
- (2014) Xin Yan et al. Molecular Cancer
- Hereditary Genes and SNPs Associated with Breast Cancer
- (2013) Kooshyar Mohammad Mahdi et al. Asian Pacific Journal of Cancer Prevention
- Assessment of HER-2 gene overexpression in Isfahan province breast cancer patients using Real Time RT-PCR and immunohistochemistry
- (2013) Hosein Tabatabaeian et al. GENE
- MALAT1 — a paradigm for long noncoding RNA function in cancer
- (2013) Tony Gutschner et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells
- (2013) Enders K. O. Ng et al. TUMOR BIOLOGY
- miRNASNP: a database of miRNA related SNPs and their effects on miRNA function
- (2012) Jing Gong et al. BMC BIOINFORMATICS
- MicroRNA-143 Targets MACC1 to Inhibit Cell Invasion and Migration in Colorectal cancer
- (2012) Yu Zhang et al. Molecular Cancer
- Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer
- (2012) R Saito et al. ONCOGENE
- The present and future of gene profiling in breast cancer
- (2011) E. Espinosa et al. CANCER AND METASTASIS REVIEWS
- MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer
- (2011) Cathy A. Andorfer et al. TRENDS IN MOLECULAR MEDICINE
- MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer
- (2009) Ming Shi et al. CANCER TREATMENT REVIEWS
- Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
- (2009) Jessica Kao et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started